Objective: Chronic scrotal pain (CSP) is one of the difficult medical evaluations. Approximately 25% of patients with chronic orchialgia have no obvious cause for the pain. The aim of this study was to identify the frequency of CSP in daily urological practice and associated diseases for our patients. Patients and Methods: In this study, 2,375 men over 18 years of age who applied to the urology outpatient clinics in our city from March 2007 to June 2007 were evaluated for chronic unilateral, bilateral or mixed orchialgia. Also evaluated was the pain score on a scale of 0 (no pain) to 10 (pain as bad as imaginable), duration of pain and pain location. Results: CSP was identified in 4.75% of the patients (113/2,375), with a mean age of 32.5 ± 10 years, and a range of 18–55 years. Associated diseases were: untidy sexual intercourse (19.5%), normal (18.6%), infertility (9.7%), varicocele (8.8%), medium and lower ureteral stones (7.1%), chronic prostatitis (5.3%), lumber pain (4.4%), stress (4.4%), epididymal cysts (4.4%), irritable bowel (4.4%), infection (3.5%), previous operation (2.7%), driving (2.7%), hernia (2.7%), and hydrocele (1.8%). Conclusion: CSP has an important place in daily urology practice with a frequency of 4.75%. It is very important to identify the reasons lying behind it and to plan effective treatment in the name of preventive medicine.

Keywords:
Chronic pain, Chronic scrotal pain, Orchialgia, Associated diseases
This content is only available via PDF.
© 2010 S. Karger AG, Basel
2010
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.